Tranexamic Acid Reduces Blood Loss in Off-Pump Coronary Artery Bypass Surgery

Objective This study was designed to evaluate the hemostatic effect of tranexamic acid in off-pump coronary artery bypass surgery. Design A prospective, randomized, double-blind, placebo-controlled study. Setting The Department of Anesthesiology and Cardiac Surgery, Medical Sciences University. Part...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiothoracic and vascular anesthesia Vol. 23; no. 3; pp. 312 - 315
Main Authors Taghaddomi, Reza Jalaeian, MD, Mirzaee, Asadollah, MD, Attar, Alireza Sharifian, MD, Shirdel, Abbas, MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective This study was designed to evaluate the hemostatic effect of tranexamic acid in off-pump coronary artery bypass surgery. Design A prospective, randomized, double-blind, placebo-controlled study. Setting The Department of Anesthesiology and Cardiac Surgery, Medical Sciences University. Participants One hundred eight patients undergoing off-pump coronary artery bypass surgery were enrolled into the study. Eight patients were withdrawn, and 100 patients were divided into 2 groups. Interventions Fifty patients received tranexamic acid (bolus 1 g before skin incision and followed by maintenance dose of 400 mg/h during surgery), and 50 patients received saline. Measurement and Main Results Hematologic parameters, volume of blood loss, blood transfusion, and other clinical data were recorded throughout the perioperative period. Twenty-four-hour postoperative blood loss was significantly less in the tranexamic acid group compared with the control group (471 ± 182 v 844 ± 303). Patients in the tranexamic acid group received significantly less allogeneic blood (8 v 31 units). Conclusion Bleeding and hemorrhagic complications and the consequent need for allogeneic transfusion are still major problems after off-pump coronary artery bypass surgery. Tranexamic acid appears to be effective in reducing postoperative bleeding and the need for allogeneic blood products.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:1053-0770
1532-8422
DOI:10.1053/j.jvca.2008.09.018